Showing results (131-140 of 145) with videos related to
Sort By:
Pageof 15
Redox Biology|January 24, 2025
Metabolic dependency mapping identifies Peroxiredoxin 1 as a driver of resistance to ATM inhibitionHaojian Li, Takashi Furusawa, Renzo Cavero, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2017
Phase I Study of ATR Inhibitor M6620 in Combination With Topotecan in Patients With Advanced Solid TumorsAnish Thomas, Christophe E Redon, Linda Sciuto, et al.Biorxiv : the Preprint Server for Biology|October 1, 2025
Lamin A/C Deficiency Drives Genomic Instability and Poor Survival in Small-Cell Lung Cancer through Increased R-loop AccumulationChristopher W Schultz, Sourav Saha, Anjali Dhall, et al.International Journal of Biological Sciences|December 18, 2014
SIRT1 deacetylates TopBP1 and modulates intra-S-phase checkpoint and DNA replication origin firingRui-Hong Wang, Tyler J Lahusen, Qiang Chen, et al.International Journal of Biological Sciences|April 9, 2010
Tumors induced in mice by direct inoculation of plasmid DNA expressing both activated H-ras and c-mycLi Sheng-Fowler, Fang Cai, Haiqing Fu, et al.Plos One|October 11, 2014
A mouse strain defective in both T cells and NK cells has enhanced sensitivity to tumor induction by plasmid DNA expressing both activated H-Ras and c-MycLi Sheng-Fowler, Wei Tu, Haiqing Fu, et al.Elife|October 28, 2020
A small protein encoded by a putative lncRNA regulates apoptosis and tumorigenicity in human colorectal cancer cellsXiao Ling Li, Lőrinc Pongor, Wei Tang, et al.The Journal of Clinical Investigation|July 8, 2025
NOTCH1 reverses immune suppression in small cell lung cancer through reactivation of STINGYoo Sun Kim, Barzin Y Nabet, Briana N Cortez, et al.Proceedings of the National Academy of Sciences of the United States of America|October 23, 2025
Lamin A/C loss promotes R-loop-mediated genomic instability and poor survival in small-cell lung cancerChristopher W Schultz, Sourav Saha, Anjali Dhall, et al.JAMA Oncology|October 12, 2023
Berzosertib Plus Topotecan vs Topotecan Alone in Patients With Relapsed Small Cell Lung Cancer: A Randomized Clinical TrialNobuyuki Takahashi, Zhonglin Hao, Liza C Villaruz, et al.Pageof 15